Earnings call transcript: Bristol-Myers Squibb Q4 2024 beats estimates
Bristol-Myers Squibb (NYSE:BMY) reported its fourth-quarter 2024 earnings, surpassing analyst expectations with an earnings ...
National Institute for Health and Care Excellence15 小时
In consultation: Guidance and quality standards
Proposed changes to appeal period for technology appraisal and highly specialised technologies appeals Methods / process manual consultation NICE process and methods 16 February 2025 Spesolimab for ...